Compound ID | 3634

Update compound information

FG-2101

Class: Small molecule antibacterial agent

Spectrum of activity: Gram-negative
Description: Synthetic compound; discovered through computational approach to identify inhibitors of metalloenzymes; currently being developed for intravenous and oral routes of administration
Institute where first reported: Blacksmith Medicines, Inc. (Blacksmith)
Year first mentioned: 2025
Highest developmental phase: Preclinical
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 589.58
Iso. SMILES: C1COCCN1CC2=CC=C(C=C2)C#CC3=CC=C(C=C3)[C@H](CC4=C(C(=O)NC=N4)OP(=O)(O)O)CN5CC(C5)C#N
InChI Key: MTAPQGVXYZUOBV-HHHXNRCGSA-N
Can. SMILES: C(#CC1=CC=C(C=C1)[C@H](CC2=C(C(=O)NC=N2)OP(=O)(O)O)CN3CC(C#N)C3)C4=CC=C(C=C4)CN5CCOCC5
InChI: InChI=1S/C30H32N5O6P/c31-16-25-18-35(19-25)20-27(15-28-29(41-42(37,38)39)30(36)33-21-32-28)26-9-7-23(8-10-26)2-1-22-3-5-24(6-4-22)17-34-11-13-40-14-12-34/h3-10,21,25,27H,11-15,17-20H2,(H,32,33,36)(H2,37,38,39)/t27-/m1/s1
External links:
Structure link: https://pubchem.ncbi.nlm.nih.gov/compound/168181248
Guide to Pharmacology: FG-2101
Citations:
  • https://blacksmithmedicines.com/blacksmith-medicines-presents-the-discovery-and-chemical-structure-of-fg-2101-a-novel-antibiotic-candidate-targeting-lpxc-at-the-american-chemical-society-acs-national-meeting/
  • https://patents.google.com/patent/US12187754B2
    • Patent: US12187754B2

    AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.